Safety and efficacy of composite collagen-silver nanoparticle hydrogels as tissue engineering scaffolds

Nanoscale. 2015 Nov 28;7(44):18789-98. doi: 10.1039/c5nr03826j. Epub 2015 Oct 28.

Abstract

The increasing number of multidrug resistant bacteria has revitalized interest in seeking alternative sources for controlling bacterial infection. Silver nanoparticles (AgNPs), are amongst the most promising candidates due to their wide microbial spectrum of action. In this work, we report on the safety and efficacy of the incorporation of collagen coated AgNPs into collagen hydrogels for tissue engineering. The resulting hybrid materials at [AgNPs] < 0.4 μM retained the mechanical properties and biocompatibility for primary human skin fibroblasts and keratinocytes of collagen hydrogels; they also displayed remarkable anti-infective properties against S. aureus, S. epidermidis, E. coli and P. aeruginosa at considerably lower concentrations than silver nitrate. Further, subcutaneous implants of materials containing 0.2 μM AgNPs in mice showed a reduction in the levels of IL-6 and other inflammation markers (CCL24, sTNFR-2, and TIMP1). Finally, an analysis of silver contents in implanted mice showed that silver accumulation primarily occurred within the tissue surrounding the implant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents* / chemistry
  • Anti-Infective Agents* / pharmacology
  • Bacteria / growth & development
  • Chemokine CCL24 / metabolism
  • Humans
  • Hydrogels* / chemistry
  • Hydrogels* / pharmacology
  • Inflammation Mediators / metabolism
  • Interleukin-6 / metabolism
  • Metal Nanoparticles / chemistry*
  • Mice
  • Receptors, Tumor Necrosis Factor, Type II / metabolism
  • Silver* / chemistry
  • Silver* / pharmacology
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Scaffolds / chemistry*

Substances

  • Anti-Infective Agents
  • Ccl24 protein, mouse
  • Chemokine CCL24
  • Hydrogels
  • Inflammation Mediators
  • Interleukin-6
  • Receptors, Tumor Necrosis Factor, Type II
  • Timp1 protein, mouse
  • Tissue Inhibitor of Metalloproteinase-1
  • Silver